Ultra Violette recalled 49,275 tubes of its Velvet Screen SPF 50 sunscreen on August 22, 2025. Testing revealed SPF levels inconsistent with the label, posing a serious risk. Consumers should stop using the product immediately.
Subpotent/Super-potent Product: Testing of the SPF 50 sunscreen revealed inconsistency in SPF results ranging from SPF 4, 10, 21, 26, 33, 60, 61, and 64.
Consumers and healthcare providers should stop using this product immediately. Contact GRACE & FIRE PTY LTD or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled products include 15 mL tubes (NDC 84803-106-01, UPC 9355909006068) and 50 mL tubes (NDC 84803-106-02, UPC 9355909005924). These products were distributed by Grace & Fire USA Inc. nationwide in the USA.
Testing revealed SPF results ranging from SPF 4 to SPF 64, which may not provide adequate sun protection. This inconsistency poses a high risk of sunburn and skin damage.
No specific incidents have been reported related to this recall. However, the potential for skin damage due to inadequate SPF levels is significant.
Consumers should stop using the recalled sunscreen immediately. Contact Grace & Fire Pty Ltd or a healthcare provider for guidance on safe alternatives.
For further information, consumers can visit the FDA website or contact Grace & Fire Pty Ltd directly.
Get instant alerts for recalls that affect you. Free forever.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Novo Nordisk recalled Wegovy (semaglutide) injections on December 19, 2025, after discovering hair in prefilled syringes. The contamination poses a serious hazard to consumers. The recall affects all units distributed nationwide.
Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.
Zydus Pharmaceuticals recalled over 2,100 bottles of TraZODONE Hydrochloride Tablets on December 19, 2025. Some tablets have surface dents that may affect medication integrity. Consumers should stop using the product immediately and seek guidance from healthcare providers.
CareFusion 213, LLC recalled 106,400 units of ChloraPrep Triple Swabsticks on December 17, 2025. The recall occurred due to a lack of assurance of sterility. Consumers must stop using the product immediately and contact CareFusion for guidance.
Merck Sharp & Dohme LLC recalled 845 kits of Noxafil Powdermix on December 12, 2025. The recall follows the discovery of potential metal particulates in the product. Consumers should stop using the medication immediately and contact their healthcare provider for further guidance.
Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.
Beaver-Visitec International recalled five units of the OME6000U Laser and Endoscopy System on December 5, 2025. The recall stems from a manufacturing deviation where ferrites required for the USB cable were not installed. This omission poses a high electrical hazard risk to patients and healthcare providers.